<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00215618</url>
  </required_header>
  <id_info>
    <org_study_id>2003-010</org_study_id>
    <nct_id>NCT00215618</nct_id>
  </id_info>
  <brief_title>Uterine Balloon Treatment for Heavy Period Bleeding.</brief_title>
  <official_title>Clinical Evaluation of Uterine Balloon Therapy System for Menorrhagia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to determine the proportion of women who achieve permanent
      cessation of bleeding after Uterine Balloon Therapy (UBT) for the treatment of heavy uterine
      bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was also designed to determine the effect of a post procedure curettage on
      bleeding patterns and post-operative discharge and pain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2003</start_date>
  <completion_date type="Actual">September 2008</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of post-procedure amenorrhea in women treated with uterine balloon therapy.</measure>
    <time_frame>6 and 12 mo</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-procedure bleeding levels</measure>
    <time_frame>2 and 3 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of post-procedure curettage on bleeding patterns, post-operative discharge and post-operative pain.</measure>
    <time_frame>2 and 3 yrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>System utility as indicated by equipment events that require intervention.</measure>
    <time_frame>perioperative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Menorrhagia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Uterine Balloon Therapy with post procedure curettage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Uterine Balloon Therapy without post-procedure curettage</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Uterine Balloon Therapy</intervention_name>
    <description>UBT with post procedure curettage</description>
    <arm_group_label>1</arm_group_label>
    <other_name>with post procedure curettage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Uterine Balloon Therapy</intervention_name>
    <description>UBT without post procedure curettage</description>
    <arm_group_label>2</arm_group_label>
    <other_name>without post procedure curettage</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female at least 30 years of age who is premenopausal and for whom childbearing is
             complete.

          -  Excessive menstrual bleeding documented by a diary score of at least 150.

          -  Have documented 3 months failed medical therapy or either a) contraindicated for or b)
             refused medical therapy.

          -  Have an anatomically normal uterine cavity sounding at least 4cm, but not greater than
             12cm.

          -  Have a normal pap smear and no unexplained abnormal pap smears within 1 year of the
             procedure.

          -  Agree not to switch from hormonal to non-hormonal contraception or vice versa during
             or just prior to the study.

          -  Agree to use reliable contraception throughout the study.

          -  Freely agree to participate in the study, including all study related procedures and
             evaluations, and document this agreement by signing informed consent documentation.

        Exclusion Criteria:

          -  Active pelvic inflammatory disease (PID) or recurrent chronic PID.

          -  Active genital or urinary tract infection at the time of the procedure.

          -  History of malignancy of the reproductive system within 5 years of the procedure or
             have ever had malignancy of the endometrium.

          -  Endometrial neoplasia, determined by endometrial biopsy taken within 6 months of
             procedure.

          -  Cavity distorting submucous myoma(s) determined by preoperative hysterogram,
             hysteroscopy, or transvaginal sonography within 6 months of the procedure.

          -  Previous endometrial ablation procedure.

          -  Previous uterine surgeries (such as full thickness myomectomy, subserosal myomectomy,
             uterine reconstruction, or any surgery in which thinning of the uterine musculature
             could occur) except for low transverse caesarean section.

          -  Pregnant or desirous of future pregnancy.

          -  Taken endometrial suppression medication, except for oral contraceptives, within 3
             months of the procedure.

          -  Concurrent open or laparoscopic surgery.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles T Cash, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oakwood Hospital and Medical Center</affiliation>
  </overall_official>
  <removed_countries>
    <country>Mexico</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2005</study_first_submitted>
  <study_first_submitted_qc>September 19, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>January 13, 2009</last_update_submitted>
  <last_update_submitted_qc>January 13, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2009</last_update_posted>
  <responsible_party>
    <name_title>David Robinson MD</name_title>
    <organization>Ethicon Inc</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menorrhagia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

